Roles for Biological Membranes in Regulating Human Immunodeficiency Virus Replication and Progress in the Development of HIV Therapeutics that Target Lipid Metabolism

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuroimmune Pharmacology

• Publication date

  2011-03-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11481-011-9274-7PMID 21445582PMCID PMC3417146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New cholesterol-specific antibodies remodel HIV-1 target cells’ surface and inhibit their in vitro virus production

  2010cited by this paper
• Greasing their way: lipid modifications determine protein association with membrane rafts.

  2010cited by this paper
• Relationships between plasma membrane microdomains and HIV‐1 assembly

  2010cited by this paper
• HIV-1 gp41 fusion intermediate: a target for HIV therapeutics.

  2010cited by this paper
• An X‐ray diffraction study of model membrane raft structures

  2010cited by this paper
• Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains.

  2010cited by this paper
• Lipid microdomains: structural correlations, fluctuations, and formation mechanisms.

  2010cited by this paper
• The Role of Lipids in Retrovirus Replication

  2010cited by this paper
• HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization.

  2009cited by this paper
• A Ceramide-binding C1 Domain Mediates Kinase Suppressor of Ras Membrane Translocation

  2009cited by this paper
• Deficiency of Niemann-Pick Type C-1 Protein Impairs Release of Human Immunodeficiency Virus Type 1 and Results in Gag Accumulation in Late Endosomal/Lysosomal Compartments

  2009cited by this paper
• Probing HIV-1 Membrane Liquid Order by Laurdan Staining Reveals Producer Cell-dependent Differences*

  2009cited by this paper
• Lipids and membrane microdomains in HIV-1 replication.

  2009cited by this paper
• Tumor necrosis factor‐α‐induced neutral sphingomyelinase‐2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors

  2009cited by this paper
• PI4P5-kinase Ialpha is required for efficient HIV-1 entry and infection of T cells.

  2008cited by this paper
• Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.

  2008cited by this paper
• Retroviruses Human Immunodeficiency Virus and Murine Leukemia Virus Are Enriched in Phosphoinositides

  2008cited by this paper
• Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry.

  2008cited by this paper
• HIV-1 gp120 in human primary macrophages CCR5-dependent, NF-kBdriven CCL2 secretion elicited in response to Phosphatidylcholine-specific phospholipase C activation is required for

  2008cited by this paper
• PI4P5-Kinase Iα Is Required for Efficient HIV-1 Entry and Infection of T Cells1

  2008cited by this paper
• Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.

  2008cited by this paper
• Alteration of viral lipid composition by expression of the phospholipid floppase ABCB4 reduces HIV vector infectivity

  2008cited by this paper
• Both Sphingomyelin Synthases SMS1 and SMS2 Are Required for Sphingomyelin Homeostasis and Growth in Human HeLa Cells*

  2007cited by this paper
• Cell Entry by Enveloped Viruses: Redox Considerations for HIV and SARS-Coronavirus

  2007cited by this paper
• Characterization of a novel alternatively spliced human transcript encoding an N-terminally truncated Vps24 protein that suppresses the effects of Bax in an ESCRT independent manner in yeast.

  2007cited by this paper
• Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells

  2007cited by this paper
• Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.

  2007cited by this paper
• Electrostatic Interactions Drive Membrane Association of the Human Immunodeficiency Virus Type 1 Gag MA Domain

  2007cited by this paper
• Direct observation of Bin/amphiphysin/Rvs (BAR) domain-induced membrane curvature by means of molecular dynamics simulations

  2006cited by this paper
• nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis.

  2006cited by this paper
• Novel Tumor Necrosis Factor-responsive Mammalian Neutral Sphingomyelinase-3 Is a C-tail-anchored Protein*

  2006cited by this paper
• A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection

  2006cited by this paper
• Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.

  2006cited by this paper
• The HIV lipidome: a raft with an unusual composition.

  2006cited by this paper
• Gag Regulates Association of Human Immunodeficiency Virus Type 1 Envelope with Detergent-Resistant Membranes

  2006cited by this paper
• C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.

  2006cited by this paper
• Alkaline sphingomyelinase: an old enzyme with novel implications.

  2006cited by this paper
• Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement.

  2005cited by this paper
• Probing phosphoinositide functions in signaling and membrane trafficking.

  2005cited by this paper
• Sphingolipids: Modulators of HIV-1 Infection and Pathogenesis

  2005cited by this paper
• Phosphatidylserine treatment relieves the block to retrovirus infection of cells expressing glycosylated virus receptors

  2005cited by this paper
• Enhancement of Enveloped Virus Entry by Phosphatidylserine

  2005cited by this paper
• Phosphoinositides in constitutive membrane traffic.

  2004cited by this paper
• Identification of a family of animal sphingomyelin synthases

  2004cited by this paper
• Ceramide, a target for antiretroviral therapy.

  2004cited by this paper
• Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia

  2004cited by this paper
• An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells

  2004cited by this paper
• Elevated Expression of GM3 in Receptor-Bearing Targets Confers Resistance to Human Immunodeficiency Virus Type 1 Fusion

  2004cited by this paper
• Human Immunodeficiency Virus Type 1 gp120 Induces Apoptosis in Human Primary Neurons through Redox-Regulated Activation of Neutral Sphingomyelinase

  2004cited by this paper
• Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.

  2004cited by this paper
• Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.

  2004cited by this paper
• Inhibition of chemokine receptor function by membrane cholesterol oxidation.

  2003cited by this paper
• Membrane incorporation of 22-hydroxycholesterol inhibits chemokine receptor activity.

  2003cited by this paper
• Contrasting Membrane Interaction Mechanisms of AP180 N-terminal Homology (ANTH) and Epsin N-terminal Homology (ENTH) Domains*

  2003cited by this paper
• Ceramide: second messenger or modulator of membrane structure and dynamics?

  2003cited by this paper
• Imaging metabolism of phosphatidylinositol 4,5-bisphosphate in T-cell GM1-enriched domains containing Ras proteins.

  2003cited by this paper
• The role of glycosphingolipids in HIV signaling, entry and pathogenesis

  2003cited by this paper
• Phosphatidylserine on HIV Envelope Is a Cofactor for Infection of Monocytic Cells1

  2003cited by this paper
• HIV-1 Entry into T-cells Is Not Dependent on CD4 and CCR5 Localization to Sphingolipid-enriched, Detergent-resistant, Raft Membrane Domains*

  2003cited by this paper
• Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells

  2002cited by this paper
• HIV-1 gp41 Envelope Residues 650–685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl Ceramide*

  2002cited by this paper
• Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5.

  2002cited by this paper
• Blocking of HIV-1 Infection by Targeting CD4 to Nonraft Membrane Domains

  2002cited by this paper
• Myristoylation as a target for inhibiting HIV assembly: Unsaturated fatty acids block viral budding

  2002cited by this paper
• A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction DOI 10.1194/jlr.M200165-JLR200

  2002cited by this paper
• A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.

  2002cited by this paper
• Sphingomyelin hydrolysis during apoptosis.

  2002cited by this paper
• Human Immunodeficiency Virus Type 1 Uses Lipid Raft-Colocalized CD4 and Chemokine Receptors for Productive Entry into CD4+ T Cells

  2002cited by this paper
• Lipid rafts: cell surface platforms for T cell signaling.

  2002cited by this paper
• CXCR4 Function Requires Membrane Cholesterol: Implications for HIV Infection

  2002cited by this paper
• A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling.

  2001cited by this paper
• Evidence for cell surface association between CXCR4 and ganglioside GM3 after gp120 binding in SupT1 lymphoblastoid cells

  2001cited by this paper
• Plasma membrane rafts play a critical role in HIV-1 assembly and release

  2001cited by this paper
• CD95 Signaling via Ceramide-rich Membrane Rafts*

  2001cited by this paper
• Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor.

  2001cited by this paper
• Lipid rafts and HIV-1: from viral entry to assembly of progeny virions.

  2001cited by this paper
• G-Protein Signaling Through Tubby Proteins

  2001cited by this paper
• Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.

  2000cited by this paper
• Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes.

  2000cited by this paper
• Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection

  2000cited by this paper
• Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase.

  2000cited by this paper
• Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion

  2000cited by this paper
• Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity.

  2000cited by this paper
• Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts

  2000cited by this paper
• Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3)

  1999cited by this paper
• CD4 segregates into specific detergent-resistant T-cell membrane microdomains.

  1999cited by this paper
• Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes.

  1999cited by this paper
• Structure and functional properties of diacylglycerols in membranes.

  1999cited by this paper
• Interplay of C1 and C2 domains of protein kinase C-alpha in its membrane binding and activation.

  1999cited by this paper
• Phosphatidylinositol 3-phosphate recognition by the FYVE domain.

  1999cited by this paper
• Interplay of C1 and C2 Domains of Protein Kinase C-α in Its Membrane Binding and Activation*

  1999cited by this paper
• Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors.

  1998cited by this paper
• Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?

  1998cited by this paper
• Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3*

  1998cited by this paper
• Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.

  1998cited by this paper
• Membrane Fusion Induced by the HIV Type 1 Fusion Peptide: Modulation by Factors Affecting Glycoprotein 41 Activity and Potential Anti-HIV Compounds

  1997cited by this paper
• Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes.

  1997cited by this paper
• The mode of ceramide action: the alkyl chain protrusion model.

  1997cited by this paper
• Morphological changes induced by phospholipase C and by sphingomyelinase on large unilamellar vesicles: a cryo-transmission electron microscopy study of liposome fusion.

  1997cited by this paper
• Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.

  1997cited by this paper

• Metabolomic Profiling Reveals Potential Biomarkers and Prominent Features in HIV/AIDS Patients Co-Infected with SARS-CoV-2

  2025cites this paper
• Mendelian randomization study of lipid species reveals causal relationship with syphilis

  2025cites this paper
• Immunometabolic interference between cancer and COVID-19

  2023cites this paper
• Rapid screening and identification of active ingredients in licorice extract interacting with V3 loop region of HIV-1 gp120 using ACE and CE-MS.

  2015cites this paper
• Cell Signaling Pathways and HIV-1 Therapeutics

  2011cites this paper